Skip to main content
. 2021 Apr 4;78(14):1309–1316. doi: 10.1093/ajhp/zxab152

Table 1.

Characteristics of Drugs Included in Final Dataset (n =1,517)

Frequency, No. (%)a
Study classification
Nonshortage drug 1,096 (72.2)
Shortage drug 421 (27.8)
Dosage form
Oral only 574 (37.8)
IV only 452 (29.8)
Oral and IV 291 (19.2)
Other 200 (13.2)
Therapeutic class
Other 676 (44.6)
Cardiovascular 227 (15.0)
Antimicrobial 207 (13.6)
Antineoplastic 160 (10.5)
Analgesic 109 (7.2)
Electrolyte 74 (4.9)
Antipsychotic 41 (2.7)
Anesthetic 23 (1.5)
Controlled substance schedule
Schedule II 78 (5.1)
Schedules III–V 53 (3.5)
Orphan drug status 250 (16.5)
Branded/generic product availability
 Both branded and generic 675 (44.5)
Generic only 458 (30.2)
Branded only 384 (25.3)
No. of manufacturers per drug, mean (SD) 4.871 (4.641)

Abbreviations: IV, intravenous; SD, standard deviation.

aUnless indicated otherwise.